03:30 AM EST, 02/19/2025 (MT Newswires) -- Chad M Robins, Director, Chief Executive Officer and Chairman, on February 13, 2025, sold 470,368 shares in Adaptive Biotechnologies ( ADPT ) for $3,985,754. Following the Form 4 filing with the SEC, Robins has control over a total of 2,576,701 common shares of the company, with 2,576,701 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1478320/000106299325002744/xslF345X05/form4.xml